Bohai Pharmaceuticals Group (BOPH) Inventory Turnover Ratio, from first quarter 2015 to first quarter 2014, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Bohai Pharmaceuticals Group, Inc.  (BOPH)
 

Bohai Pharmaceuticals Group Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Bohai Pharmaceuticals Group, Inc. inventory turnover ratio, the Bohai Pharmaceuticals Group, Inc.'s ability to sell and replace its inventory in the first quarter 2015, sequentially increased to 9.58 in the first quarter 2014, BOPH's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Bohai Pharmaceuticals Group in Sep 30 2014 quarter, has decreased to 38 days, compare to 40 days, in the Jun 30 2014 quarter.

Within Healthcare sector 24 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2015, to 450, from total ranking in the fourth quarter 2014 at 477.

BOPH Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Bohai Pharmaceuticals Group, Inc. Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BOPH Inventory Turnover Ratio (Sep 30 2014)
I. Quarter		 (Jun 30 2014)
IV. Quarter		 (Mar 31 2014)
III. Quarter		 (Dec 31 2013)
II. Quarter		 (Sep 30 2013)
I. Quarter
Y / Y Inventory Growth 11.26 % 61.81 % 45.21 % 53.74 % 9.76 %
Y / Y Cost of Sales Growth 32.68 % -1.65 % 22.26 % 4.79 % 36.26 %
Inventory Turnover Ratio (TTM) 9.58 9.03 9.99 10.42 11.62
BOPH's Total Ranking # 450 # 477 # 564 # 563 # 474
Average inventory processing period 38 40 37 35 31
Seq. Inventory Growth 16.51 % -0.08 % -10.67 % 6.99 % 69.44 %
Seq. Cost of Sales Growth 35.11 % 13.55 % 11.93 % -22.73 % 0.15 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 1
Healthcare Sector # 25
Overall Market # 450

Inventory Turnover Ratio Statistics
High Average Low
11.62 8.23 2.19
(Sep 30 2013)   (Jun 30 2012)



BOPH Company Profile >> Back to BOPH Efficiency Comparisons >> Compare BOPH Inventory Turnover Ratio to its Competitors

Financial Statements
Bohai Pharmaceuticals Group's Inventories $ 5 Millions Visit BOPH's Balance sheet
Bohai Pharmaceuticals Group's Cost of Revenues TTM $ 46 Millions Visit BOPH's Income Statement
What are BOPH's Sales? Visit BOPH's Sales by Segment

Other Inventory Turnover Ratios
Bohai Pharmaceuticals Group's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BOPH's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BOPH's Competitors
Inventory Turnover Ratio for BOPH's Suppliers
Inventory Turnover Ratio for BOPH's Customers

You may also want to know
BOPH's Sales Growth Rates BOPH's Pe Price to earnings ratio BOPH's Receivables Turnover Ratio BOPH's Stock Quote
BOPH's Net Income Growth Rates BOPH's Ps Price to Sales ratio BOPH's Sales per Employee BOPH's Asset Turnover Ratio
BOPH's Net Margin BOPH's Pb Price to Book ratio BOPH's Financial Strength Ratios BOPH's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2014, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2014 Inventories at quarter ending Sep 30 2014
Hca Healthcare Inc   21.13 $ 25,545.000  Millions$ 1,209  Millions
Option Care Health Inc   20.50 $ 703.856  Millions$ 34  Millions
Bioxytran Inc   17.10 $ 0.228  Millions$ 0  Millions
Clearday Inc   16.27 $ 1.253  Millions$ 0  Millions
Rockwell Medical inc   15.92 $ 45.677  Millions$ 3  Millions
Insulet Corporation  15.13 $ 145.059  Millions$ 10  Millions
Sanomedics, Inc.  13.98 $ 0.321  Millions$ 0  Millions
Align Technology inc   12.34 $ 181.673  Millions$ 15  Millions
Immunogen inc   11.39 $ 30.060  Millions$ 3  Millions
Perspective Therapeutics Inc   11.10 $ 4.385  Millions$ 0  Millions
Fonar Corporation  10.30 $ 25.590  Millions$ 2  Millions
Henry Schein Inc   9.87 $ 12,427.076  Millions$ 1,260  Millions
Biolife Solutions Inc   9.71 $ 5.134  Millions$ 1  Millions
Bohai Pharmaceuticals Group, Inc.  9.58 $ 46.202  Millions$ 5  Millions
China Yct International Group, Inc.  9.20 $ 17.030  Millions$ 2  Millions
Inotiv Inc   9.17 $ 13.889  Millions$ 2  Millions
Star Equity Holdings Inc   8.91 $ 32.681  Millions$ 4  Millions
Wearable Health Solutions, Inc.  8.62 $ 0.325  Millions$ 0  Millions
Lisata Therapeutics Inc   8.59 $ 14.859  Millions$ 2  Millions
Nutrastar International Inc.  8.54 $ 9.725  Millions$ 1  Millions
Infusystem Holdings Inc  8.50 $ 12.124  Millions$ 1  Millions
Omnova Solutions Inc  8.07 $ 796.200  Millions$ 99  Millions
Genmark Diagnostics Inc   8.00 $ 13.112  Millions$ 2  Millions
Ufp Technologies Inc   7.97 $ 99.980  Millions$ 13  Millions
China Health Industries Holdings Inc   7.95 $ 8.202  Millions$ 1  Millions
Windtree Therapeutics Inc  7.90 $ 2.286  Millions$ 0  Millions
Kewaunee Scientific Corporation  7.48 $ 91.324  Millions$ 12  Millions
Tenet Healthcare Corp  7.41 $ 1,942.000  Millions$ 262  Millions
Micron Solutions Inc  7.01 $ 19.839  Millions$ 3  Millions
Dexcom Inc   6.76 $ 74.013  Millions$ 11  Millions

Date modified: 2026-08-29T17:35:58+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.